DEUTSCHE BANK AG\ - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 71 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$36,000
-98.6%
327,995
-78.5%
0.00%
-100.0%
Q3 2018$2,592,000
-6.0%
1,526,271
-3.7%
0.00%0.0%
Q2 2018$2,756,000
+15.2%
1,584,883
+21.2%
0.00%0.0%
Q1 2018$2,392,000
-50.4%
1,308,043
-39.5%
0.00%
-66.7%
Q4 2017$4,818,000
-30.3%
2,161,529
-9.3%
0.00%
-40.0%
Q3 2017$6,912,000
+48.4%
2,384,000
+127.7%
0.01%
+66.7%
Q2 2017$4,657,000
+224.8%
1,046,905
+239.9%
0.00%
+200.0%
Q1 2017$1,434,000
+80.2%
307,999
+135.1%
0.00%0.0%
Q4 2016$796,000
-83.9%
131,004
-85.4%
0.00%
-66.7%
Q3 2016$4,939,000
+50.1%
896,493
+3.4%
0.00%
+50.0%
Q2 2016$3,291,000
+91.9%
866,716
+39.3%
0.00%
+100.0%
Q1 2016$1,715,000
-57.9%
622,044
-13.4%
0.00%
-66.7%
Q4 2015$4,073,000
-21.5%
718,450
-26.6%
0.00%
-25.0%
Q3 2015$5,188,000
+719.6%
979,132
+1181.7%
0.00%
Q2 2015$633,000
+99.1%
76,396
+9.9%
0.00%
Q1 2015$318,000
-6.2%
69,506
-37.8%
0.00%
Q4 2014$339,000
+153.0%
111,781
+129.8%
0.00%
Q3 2014$134,000
+8.1%
48,642
+58.0%
0.00%
Q2 2014$124,000
-79.3%
30,785
-72.8%
0.00%
Q1 2014$599,000
+8.7%
113,019
+15.3%
0.00%
Q4 2013$551,000
-75.7%
97,998
-80.3%
0.00%
-100.0%
Q3 2013$2,270,000497,1450.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2013
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 477,621$1,065,0001.44%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,804$3,358,0001.18%
Nantahala Capital Management 7,000,000$15,610,0000.69%
Hikari Power Ltd 1,900,000$4,237,0000.50%
Trellus Management Company, LLC 112,500$251,0000.34%
Cheyne Capital Management (UK) LLP 206,500$462,0000.20%
KNOTT DAVID M 201,400$449,0000.18%
Paulson & Co. 4,000,000$8,920,0000.17%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,041,695$2,323,0000.15%
Clear Harbor Asset Management, LLC 318,460$710,0000.13%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders